Lipid–drug conjugate for enhancing drug delivery
D Irby, C Du, F Li - Molecular pharmaceutics, 2017 - ACS Publications
Lipid–drug conjugates (LDCs) are drug molecules that have been covalently modified with
lipids. The conjugation of lipids to drug molecules increases lipophilicity and also changes …
lipids. The conjugation of lipids to drug molecules increases lipophilicity and also changes …
Overcoming multidrug resistance in cancer: Recent progress in nanotechnology and new horizons
Multidrug resistance (MDR), defined as the ability of cancer cells to gain resistance to both
conventional and novel chemotherapy agents, is an important barrier in treating …
conventional and novel chemotherapy agents, is an important barrier in treating …
[HTML][HTML] Paclitaxel nano-delivery systems: a comprehensive review
P Ma, RJ Mumper - Journal of nanomedicine & nanotechnology, 2013 - ncbi.nlm.nih.gov
Paclitaxel is one of the most effective chemotherapeutic drugs ever developed and is active
against a broad range of cancers, such as lung, ovarian, and breast cancers. Due to its low …
against a broad range of cancers, such as lung, ovarian, and breast cancers. Due to its low …
Nanodrug delivery in reversing multidrug resistance in cancer cells
S Kapse-Mistry, T Govender, R Srivastava… - Frontiers in …, 2014 - frontiersin.org
Different mechanisms in cancer cells become resistant to one or more chemotherapeutics is
known as multidrug resistance (MDR) which hinders chemotherapy efficacy. Potential …
known as multidrug resistance (MDR) which hinders chemotherapy efficacy. Potential …
Hyaluronic acid-coated liposomes for targeted delivery of paclitaxel, in-vitro characterization and in-vivo evaluation
Breast cancer is the leading cause of cancer death in women. Chemotherapy is regarded as
the most essential strategy in inhibiting the proliferation of tumor cells. Paclitaxel is a widely …
the most essential strategy in inhibiting the proliferation of tumor cells. Paclitaxel is a widely …
Self-assembled lipid–prodrug nanoparticles
Nanomedicines suffer from poor drug loading and uncontrolled 'burst release'after
administration. Combining prodrug strategies with nanostructured carriers can help to …
administration. Combining prodrug strategies with nanostructured carriers can help to …
Nanoparticles for imaging and treatment of metastatic breast cancer
Introduction: Metastatic breast cancer is one of the most devastating cancers that have no
cure. Many therapeutic and diagnostic strategies have been extensively studied in the past …
cure. Many therapeutic and diagnostic strategies have been extensively studied in the past …
Nanoscale drug delivery systems for cancer therapy using paclitaxel—A review of challenges and latest progressions
Paclitaxel (PTX) is an effective anticancer chemical with a broad spectrum that was primarily
obtained from a curative shrub, specifically the bark of Taxus brevifolia tree. It belongs to a …
obtained from a curative shrub, specifically the bark of Taxus brevifolia tree. It belongs to a …
Anthracycline nano-delivery systems to overcome multiple drug resistance: A comprehensive review
P Ma, RJ Mumper - Nano today, 2013 - Elsevier
Anthracyclines (doxorubicin, daunorubicin, and idarubicin) are very effective
chemotherapeutic drugs to treat many cancers; however, the development of multiple drug …
chemotherapeutic drugs to treat many cancers; however, the development of multiple drug …
Lipid prodrug nanocarriers in cancer therapy
Application of nanotechnology in the medical field (ie, nanomedicine) plays an important
role in the development of novel drug delivery methods. Nanoscale drug delivery systems …
role in the development of novel drug delivery methods. Nanoscale drug delivery systems …